Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$21.2 - $31.03 $13,419 - $19,641
-633 Reduced 1.51%
41,386 $1.27 Million
Q3 2023

Nov 03, 2023

BUY
$26.2 - $36.08 $15,851 - $21,828
605 Added 1.46%
42,019 $1.13 Million
Q2 2023

Aug 10, 2023

SELL
$25.16 - $41.38 $2,666 - $4,386
-106 Reduced 0.26%
41,414 $1.48 Million
Q1 2023

May 15, 2023

BUY
$23.68 - $38.51 $983,193 - $1.6 Million
41,520 New
41,520 $1.05 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.23B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Ci Private Wealth, LLC Portfolio

Follow Ci Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ci Private Wealth, LLC with notifications on news.